Profile data is unavailable for this security.
About the company
Sunshine Guojian Pharmaceutical Shanghai Co Ltd is a China-based company principally engaged in the research, development, production and sales of antibody drugs. The Company focuses on the research of new technologies such as monoclonal antibodies, bispecific antibodies, polyspecific antibodies and multifunctional recombinant proteins. The Company's main products include Yisaipu (recombinant human type II tumor necrosis factor receptor-antibody fusion protein), Saiputing (Initutumab for injection) and Jiannipa (recombinant anti-CD25 humanized monoclonal antibody injection). The Company's products are mainly used in the fields of breast cancer, rheumatism and autoimmune diseases. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in CNY (TTM)1.37bn
- Net income in CNY870.39m
- Incorporated2002
- Employees995.00
- LocationSunshine Guojian Pharmaceutical Shanghai Co LtdNo.399 Libing RoadChina (Shanghai) Pilot Free Trade ZoneSHANGHAI 201203ChinaCHN
- Phone+86 2 183297676
- Fax+86 2 180297676
- Websitehttps://www.3s-guojian.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bluestar Adisseo Co | 17.09bn | 1.19bn | 30.80bn | 2.93k | 22.49 | 1.59 | -- | 1.80 | 0.4447 | 0.4447 | 6.37 | 6.31 | 0.7204 | 5.30 | 8.18 | 5,834,541.00 | 5.03 | 5.20 | 6.05 | 6.63 | 27.69 | 29.69 | 6.99 | 8.12 | 1.12 | 10.31 | 0.1377 | 30.01 | 17.83 | 6.88 | 2,208.66 | 3.95 | 5.53 | -7.02 |
| Humanwell Healthcare Group Co Ltd | 24.18bn | 1.43bn | 30.87bn | 17.65k | 21.63 | 1.63 | -- | 1.28 | 0.8741 | 0.8741 | 14.84 | 11.59 | 0.6519 | 3.63 | 2.48 | 1,369,715.00 | 5.00 | 6.40 | 8.73 | 12.55 | 44.53 | 43.83 | 7.67 | 9.90 | 1.40 | 362.14 | 0.2889 | 25.97 | 3.71 | 3.13 | -37.70 | 11.15 | 4.75 | 56.54 |
| Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd | 5.37bn | 3.58bn | 31.26bn | 3.84k | 10.03 | 3.99 | -- | 5.83 | 4.65 | 4.65 | 6.98 | 11.70 | 0.4758 | 1.35 | 3.16 | 1,399,130.00 | 31.64 | 11.74 | 45.06 | 16.76 | 64.27 | 42.04 | 66.50 | 14.81 | 2.33 | -- | 0.0056 | 54.04 | -11.14 | 0.8791 | 125.94 | 28.94 | -10.54 | 33.67 |
| Shanghai Junshi Biosciences Co Ltd | 2.48bn | -949.86m | 32.48bn | 2.67k | -- | 5.90 | -- | 13.08 | -0.96 | -0.96 | 2.51 | 6.05 | 0.2203 | 0.8436 | 5.48 | 963,148.80 | -9.45 | -17.61 | -12.31 | -22.00 | 81.59 | 68.46 | -42.92 | -84.56 | 1.43 | -23.04 | 0.3629 | -- | 29.67 | 20.24 | 43.90 | -- | -4.33 | -- |
| Beijing Tiantan Biological Products Corp | 6.42bn | 1.32bn | 32.63bn | 5.30k | 24.79 | 2.85 | -- | 5.08 | 0.6656 | 0.6656 | 3.25 | 5.80 | 0.4002 | 0.9382 | 11.21 | 1,212,453.00 | 11.25 | 11.93 | 16.06 | 16.79 | 45.65 | 50.69 | 28.10 | 29.69 | 3.08 | -- | 0.0152 | 16.24 | 16.44 | 12.94 | 39.58 | 20.45 | 15.19 | 23.56 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.37bn | 870.39m | 37.38bn | 995.00 | 43.14 | 6.32 | -- | 27.28 | 1.40 | 1.40 | 2.21 | 9.56 | 0.186 | 1.54 | 4.55 | 1,377,045.00 | 11.66 | 3.14 | 15.35 | 3.34 | 74.88 | 77.37 | 62.65 | 16.95 | 1.97 | -- | 0.00 | 12.57 | 17.70 | 0.2733 | 139.15 | 25.17 | 16.61 | -- |
| Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd | 77.54bn | 2.99bn | 39.60bn | 28.14k | 13.88 | 1.09 | -- | 0.5107 | 1.84 | 1.84 | 47.69 | 23.32 | 0.9548 | 5.79 | 4.33 | 2,755,662.00 | 3.83 | 5.33 | 7.36 | 10.95 | 16.23 | 18.07 | 4.01 | 5.28 | 1.31 | -- | 0.2873 | 28.87 | -0.692 | 2.92 | -30.09 | -2.32 | -14.01 | 6.32 |
| Gan & Lee Pharmaceuticals | 3.85bn | 925.74m | 39.76bn | 5.25k | 42.45 | 3.53 | -- | 10.33 | 1.57 | 1.57 | 6.54 | 18.88 | 0.3158 | 0.9071 | 9.73 | 733,533.10 | 7.60 | 6.19 | 8.10 | 6.58 | 74.62 | 81.80 | 24.06 | 22.31 | 5.57 | -- | 0.001 | 44.12 | 16.77 | 1.02 | 80.75 | -12.04 | 1.63 | -- |
| Beijing Tong Ren Tang Co Ltd | 18.09bn | 1.35bn | 42.63bn | 17.88k | 31.48 | 3.12 | -- | 2.36 | 0.9871 | 0.9871 | 13.19 | 9.96 | 0.5736 | 0.9376 | 11.40 | 1,011,323.00 | 5.99 | 8.13 | 11.72 | 15.95 | 43.19 | 46.02 | 10.45 | 13.34 | 1.89 | -- | 0.1629 | 33.28 | 4.12 | 6.97 | -8.54 | 9.14 | 2.30 | 5.64 |
Data as of Feb 11 2026. Currency figures normalised to Sunshine Guojian Pharmaceutical Shanghai Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
4.95%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 6.77m | 1.10% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 4.86m | 0.79% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 4.61m | 0.75% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2025 | 3.35m | 0.54% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 3.06m | 0.50% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.74m | 0.28% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2025 | 1.68m | 0.27% |
| Bank of Communications Schroder Fund Management Co., Ltd.as of 30 Jun 2025 | 1.59m | 0.26% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 1.55m | 0.25% |
| China Fund Management Co., Ltd.as of 30 Jun 2025 | 1.30m | 0.21% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
